Jan 04, 2024 / 10:00PM GMT
Operator
Hello. Thank you for standing by, and welcome to the Allogene Therapeutics 2024 platform vision conference call. After the speakers' presentation, there will be a question and answer session. (Operator instructions) Please be aware that today's conference is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Corporate Affairs and brand strategy Officer. Ms. Cassiano, please go ahead.
Christine Cassiano Allogene Therapeutics - Inc. - EVP, Chief Corporate Affairs & Brand Strategy Officer
Thank you, operator, and Happy New Year. Today after market close, Allogene issued a press release that previews our 2024 platform vision, which we will also discuss at our upcoming JPMorgan presentation on January 10. We also issued a joint press release of foresight diagnosis. Today's press releases and this webcast are available on our website. Following our prepared remarks, we will host a Q&A session. We ask you to limit your questions to one per person, and we will keep this call to an hour and do our best to get to as many questions
Allogene Therapeutics Inc Platform Vision Call Transcript
Jan 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers